The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.
about
Effects of alpha fetoprotein on escape of Bel 7402 cells from attack of lymphocytes.Transfection of apoptosis related gene Fas ligand in human hepatocellular carcinoma cells and its significance in apoptosis.The prognostic molecular markers in hepatocellular carcinoma.Apoptosis as a mechanism for liver disease progression.Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cellsOxysterol-binding protein-related protein 8 (ORP8) increases sensitivity of hepatocellular carcinoma cells to Fas-mediated apoptosisApoptosis: a mechanism of acute and chronic liver injuryIntratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation.The role of death receptor ligands in shaping tumor microenvironment.Corticotropin-releasing hormone (CRH) is expressed in the human cervical carcinoma cells (HeLa) and upregulates the expression of Fas ligand.Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expressionFas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.Dysregulation of apoptosis in hepatocellular carcinoma cells.Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system.Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome.c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications.
P2860
Q24810634-751BB451-D313-442B-A82F-928F4D72EE08Q31162726-5847BDA3-65A9-41E6-B3EA-BFDAA3986896Q34668320-08CADAD5-983E-497C-AB61-1E90350D6FBDQ34764471-BAD5AE9B-6332-499C-8347-EE0E049E0D11Q35010607-99C322B4-FB16-49A2-9A7E-20C4EA6C63CCQ35580786-1613054F-F50F-42BB-8DC5-970837613A82Q36160716-4C701296-72D9-42E1-93E1-6BEA708DF495Q36611112-6469F064-04B4-4CF8-8A30-35243B2B5632Q36693120-6FE52F2E-AC75-40EB-8358-5B5E817B00E1Q39257328-2D35051A-678F-4788-A750-8A39C7A8F808Q39289574-DF38B33F-C431-4E64-8997-EE997004DAA0Q40744644-2C1506A9-E53C-4C6F-B4C5-464B1DAA2A05Q43166036-4124FC8C-091F-4C8A-B667-3B92A646216BQ43211650-B1E73D55-4180-42F7-B5C2-24135B23018BQ46957617-F8235783-A311-4034-82A8-8DE67E7D1786Q52579698-FE8B23ED-4069-411E-9DCF-01D0BBA34075
P2860
The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
The status of Fas and Fas liga ...... e of hepatocellular carcinoma.
@ast
The status of Fas and Fas liga ...... e of hepatocellular carcinoma.
@en
type
label
The status of Fas and Fas liga ...... e of hepatocellular carcinoma.
@ast
The status of Fas and Fas liga ...... e of hepatocellular carcinoma.
@en
prefLabel
The status of Fas and Fas liga ...... e of hepatocellular carcinoma.
@ast
The status of Fas and Fas liga ...... e of hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
The status of Fas and Fas liga ...... e of hepatocellular carcinoma.
@en
P2093
Matsuura N
Nakahara M
Nakamori S
Nakamura M
P2860
P2888
P304
P356
10.1054/BJOC.1999.1065
P407
P577
2000-03-01T00:00:00Z
P5875
P6179
1015760193